Objective: To evaluate the effectiveness and safety of rituximab combined with chemotherapy on diffused large B cell lymphoma (DLBCL) in clinic.

• 摘要目的：探讨利妥昔单抗联合化疗治疗弥漫型大B细胞淋巴瘤患者的临床疗效和安全性。